Neuroproteomic tools for battling Alzheimer's disease

ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology

(2016) Nobutaka Sakae et al.   JOURNAL OF NEUROSCIENCE

Prognostic Value of YKL-40 in Patients with Glioblastoma: a Systematic Review and Meta-analysis

(2016) Gang Qin et al.   MOLECULAR NEUROBIOLOGY

Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases

(2016) Gianluigi Forloni et al.   MOVEMENT DISORDERS

Regulation of global gene expression and cell proliferation by APP

(2016) Yili Wu et al.   Scientific Reports

A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans

(2016) Mikko Hölttä et al.   Alzheimers Research & Therapy

Neuropsychiatric Symptoms in Parkinson’s Disease Dementia Are More Similar to Alzheimer’s Disease than Dementia with Lewy Bodies: A Case-Control Study

(2016) Pai-Yi Chiu et al.   PLoS One

Neuropathologically mixed Alzheimer’s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes

(2015) Lauren Walker et al.   ACTA NEUROPATHOLOGICA

2015 Alzheimer's disease facts and figures

(2015)   Alzheimers & Dementia

Characterization of Dementia and Alzheimer’s Disease in an Older Population: Updated Incidence and Life Expectancy With and Without Dementia

(2015) Sarah E. Tom et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Homodimerization Protects the Amyloid Precursor Protein C99 Fragment from Cleavage by γ-Secretase

(2015) Edith Winkler et al.   BIOCHEMISTRY

Amyloid biomarkers in Alzheimer's disease

(2015) Kaj Blennow et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Genetic markers for diagnosis and pathogenesis of Alzheimer's disease

(2014) Dong Hee Kim et al.   GENE

Brain metabolite clearance: impact on Alzheimer’s disease

(2014) Juan M. Zolezzi et al.   METABOLIC BRAIN DISEASE

Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits

(2014) Nicholas J. Izzo et al.   PLoS One

Testican-3: a brain-specific proteoglycan member of the BM-40/SPARC/osteonectin family

(2013) Ursula Hartmann et al.   JOURNAL OF NEUROCHEMISTRY

Monetary Costs of Dementia in the United States

(2013) Michael D. Hurd et al.   NEW ENGLAND JOURNAL OF MEDICINE

A γ-secretase inhibitor decreases amyloid-β production in the central nervous system

(2009) Randall J. Bateman et al.   ANNALS OF NEUROLOGY

The Role of Apolipoprotein E in Alzheimer's Disease

(2009) Jungsu Kim et al.   NEURON